References
- Gao Z, Wu N, Du X, et al. Toxic nephropathy secondary to chronic mercury poisoning: clinical characteristics and outcomes. Kidney Int Rep. 2022;7(6):1189–1197.
- Sethi S. New antigens in membranous nephropathy. J Am Soc Nephrol. 2021;32(2):268–278.
- Abraham Kurien A, Jansi Prema KS, Walker PD, et al. Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy. Kidney Int. 2022;102:1424–1426.
- Pathak N, Gunasekaran I, Ambriose M, et al. Nell 1 as target antigen for mercury related membranous nephropathy: a case report. Indian J Nephrol. 2022;32(5):502–505.
- Sethi S, Debiec H, Madden B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 2020;97(1):163–174.
- Wang G, Sun L, Dong H, et al. Neural epidermal growth factor-like 1 protein-positive membranous nephropathy in Chinese patients. Clin J Am Soc Nephrol. 2021;16(5):727–735.
- Spain RI, Andeen NK, Gibson PC, et al. Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy. Kidney Int. 2021;100(6):1208–1213.
- Crowe W, Allsopp PJ, Watson GE, et al. Mercury as an environmental stimulus in the development of autoimmunity – a systematic review. Autoimmun Rev. 2017;16(1):72–80.
- Forbesindia; 2023. Available from: https://www.forbesindia.com/article/special/tracing-the-multibillion-dollar-fairness-cream-market-in-india/60371/1
- Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol. 2007;18(6):1899–1904.